Mobile

Study to assess the efficacy and safety of a new contraceptive vaginal ring containing etonogestrel and estradiol and a marketed oral contraceptive pill containing levonorgestrel and ethinyl-estradiol

Mise à jour : Il y a 4 ans
Référence : EUCTR2014-002208-26

Femme Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

1. To assess the contraceptive efficacy of the ENG-E2 vaginal ring in women 18 and 35 years of age based on the number of in treatment pregnancies as expressed by the Pearl Index (PI) in the restricted full analysis set population (rFAS) which excludes cycles in which back-up contraception was used. 2. To assess the safety and tolerability of the ENG-E2 vaginal ring.

Critère d'inclusion

  • Contraception

Liens